Difference between revisions of "Part:BBa K1028000"

(→‎Usage and Experimental Data)
(→‎Introduction)
 
(5 intermediate revisions by the same user not shown)
Line 6: Line 6:
 
<br>
 
<br>
 
<html>
 
<html>
−
<img src="http://i276.photobucket.com/albums/kk29/JosephBeetBeet/d9a54a14-fa9a-4957-b11b-95d7323de4bf.jpg" style="width:200px;margin-left:160px"  ></a>
+
<img src="http://i276.photobucket.com/albums/kk29/JosephBeetBeet/Si4bindingpeptide.jpg" style="width:350px;margin-left:160px"  ></a>
  
 
<p style="text-align:left"><b>Figure.1</b> Illustrated schematic of the Si4 Binding Peptide binding with a silica microsphere.
 
<p style="text-align:left"><b>Figure.1</b> Illustrated schematic of the Si4 Binding Peptide binding with a silica microsphere.
 
</p></html>
 
</p></html>
 
<br>
 
<br>
−
This part was originally designed by the Leeds 2013 iGEM team to bind with silica microspheres, designed to act as pathogen surrogates, when presented on the exterior of the plasma membrane via fusion with Ice Nucleation Protein.  
+
This part was originally designed by the Leeds 2013 iGEM team to bind with silica microspheres, designed to act as pathogen surrogates, when presented on the exterior of the plasma membrane via fusion with Ice Nucleation Protein.
  
 
=== '''Usage and Experimental Data''' ===
 
=== '''Usage and Experimental Data''' ===
−
<html>
 
−
<img src="https://static.igem.org/mediawiki/2013/c/cc/Leeds_BS2Growthcurve.png" style="width:500px;margin-right:160px"  ></a>
 
−
 
−
<p style="text-align:center"><b>Fig.1:</b> Monitoring the growth rate of cells containing Si4 Binding Peptide within the PSB1C3 standard iGEM submission plasmid. Although the graph shows a log and a lag phase for the cells containing the insert plasmid, the absorbance reached in log phase is very low compared to the control cells.
 
−
</p></html>
 
  
 +
The experimental data acquired regarding this part is shown on the page for its sister part [https://parts.igem.org/Part:BBa_K1028001#Introduction BBa_K1028001]. The Si4 Binding Peptide was tested in unison with INP as an INP.Si4 complex to allow expression in the extracellular space via the plasma membrane.
  
  

Latest revision as of 16:17, 4 October 2013

Silica binding peptide

Introduction

This BioBrick is a short peptide of 15 amino acids designed to act as a tag binding with high affinity to silica and silica-like particles. As a tag it can easily be added to the C-terminus of proteins using molecular biology techniques allowing the peptide to assist with purification or to serve other experimental processes related to silica binding.

Figure.1 Illustrated schematic of the Si4 Binding Peptide binding with a silica microsphere.


This part was originally designed by the Leeds 2013 iGEM team to bind with silica microspheres, designed to act as pathogen surrogates, when presented on the exterior of the plasma membrane via fusion with Ice Nucleation Protein.

Usage and Experimental Data

The experimental data acquired regarding this part is shown on the page for its sister part BBa_K1028001. The Si4 Binding Peptide was tested in unison with INP as an INP.Si4 complex to allow expression in the extracellular space via the plasma membrane.


Sequence and Features


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    COMPATIBLE WITH RFC[12]
  • 21
    COMPATIBLE WITH RFC[21]
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    COMPATIBLE WITH RFC[25]
  • 1000
    COMPATIBLE WITH RFC[1000]